Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas Hughes Insider Profile
4 Followers
Thomas Hughes, President and Chief Scientific Officer, Director at Larimar Therapeutics, holds 12.83K shares in Viridian Therapeutics (Ticker: VRDN), holds 125.25K shares in Larimar Therapeutics (Ticker: LRMR). Most recently, Thomas Hughes Bought ― shares of Viridian Therapeutics on Oct 12, 2018 for an estimated value of 47.60K.
Thomas Hughes Larimar Therapeutics (LRMR)President and Chief Scientific Officer, Director
Larimar Therapeutics (LRMR)
President and Chief Scientific Officer, Director
Ranked #82,464 out of 98,564 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-25.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Thomas Hughes holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 15, 2017 - May 15, 2018
Return:+53.70%
The most profitable trade made by Thomas Hughes
Thomas Hughes's Trading History
Larimar Therapeutics
Jun 29, 2018
President and Chief Scientific Officer, Director
Uninformative Sell
320.00K
$809.10K
Viridian Therapeutics
Oct 12, 2018
Director
Informative Buy
47.60K
$182.78K
List of latest transactions for each holding click on a transaction to see Thomas Hughes's performance on stock
You May Also Like
Thomas Hughes insider profile FAQ
What is the percentage of profitable transactions made by Thomas Hughes?
The percentage of profitable transactions made by Thomas Hughes is 40%.
What is the average return per transaction made by Thomas Hughes?
The average return per transaction made by Thomas Hughes is -25.50%.
What stocks does Thomas Hughes hold?
Thomas Hughes holds: LRMR, VRDN stocks.
What was Thomas Hughes’s latest transaction?
Thomas Hughes latest transaction was an Informative Buy of $47.60K.
What was Thomas Hughes's most profitable transaction?
Thomas Hughes’s most profitable transaction was an Informative Buy of LRMR stock on May 15, 2017. The return on the trade was 53.70%.
What is Thomas Hughes's role in Larimar Therapeutics?
Thomas Hughes's role in Larimar Therapeutics is President and Chief Scientific Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.